These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30519981)

  • 1. Urine proteomic profiling in patients with nephrolithiasis and cystinuria.
    Kovacevic L; Caruso JA; Lu H; Kovacevic N; Lakshmanan Y; Carruthers NJ; Goldfarb DS
    Int Urol Nephrol; 2019 Apr; 51(4):593-599. PubMed ID: 30519981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine proteomic analysis in cystinuric children with renal stones.
    Kovacevic L; Lu H; Goldfarb DS; Lakshmanan Y; Caruso JA
    J Pediatr Urol; 2015 Aug; 11(4):217.e1-6. PubMed ID: 26076823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteomics reveals association between pediatric nephrolithiasis and cardiovascular disease.
    Kovacevic L; Lu H; Caruso JA; Kovacevic N; Lakshmanan Y
    Int Urol Nephrol; 2018 Nov; 50(11):1949-1954. PubMed ID: 30209738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of inhibitory protein profiles in the urine of children with nephrolithiasis: implication for disease prevention.
    Kovacevic L; Kovacevic N; Lakshmanan Y
    Int Urol Nephrol; 2022 Nov; 54(11):2783-2788. PubMed ID: 35879498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystine as a risk factor of the stone formation in kidney: the reference value range of urinary excretion, the stage diagnosis of cystine metabolism disorder].
    Gres AA; Nitkin DM; Juraha TM; Sivakow AA
    Urologiia; 2016 Aug; (4):10-14. PubMed ID: 28247719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation.
    Lambert EH; Asplin JR; Herrell SD; Miller NL
    J Endourol; 2010 Jul; 24(7):1179-82. PubMed ID: 20624086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.
    Sakhaee K; Poindexter JR; Pak CY
    J Urol; 1989 Apr; 141(4):819-21. PubMed ID: 2926871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria.
    Kovacevic L; Lu H; Caruso JA; Govil-Dalela T; Thomas R; Lakshmanan Y
    Pediatr Nephrol; 2017 Jun; 32(6):1029-1033. PubMed ID: 28188435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.
    Kovacevic L; Lu H; Caruso JA; Lakshmanan Y
    Urology; 2016 Jun; 92():100-5. PubMed ID: 26892647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients.
    Bourderioux M; Nguyen-Khoa T; Chhuon C; Jeanson L; Tondelier D; Walczak M; Ollero M; Bekri S; Knebelmann B; Escudier E; Escudier B; Edelman A; Guerrera IC
    J Proteome Res; 2015 Jan; 14(1):567-77. PubMed ID: 25365230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the natural history of presymptomatic cystinuria.
    Tokhmafshan F; Goodyer PR
    Curr Opin Nephrol Hypertens; 2023 May; 32(3):297-304. PubMed ID: 37013453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of cystine supersaturation measurements.
    Nakagawa Y; Asplin JR; Goldfarb DS; Parks JH; Coe FL
    J Urol; 2000 Nov; 164(5):1481-5. PubMed ID: 11025687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystinuria subtype and the risk of nephrolithiasis.
    Goodyer P; Saadi I; Ong P; Elkas G; Rozen R
    Kidney Int; 1998 Jul; 54(1):56-61. PubMed ID: 9648063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of urine alkalization on urinary inflammatory markers in cystinuric patients.
    Prot-Bertoye C; Jung V; Tostivint I; Roger K; Benoist JF; Jannot AS; Van Straaten A; Knebelmann B; Guerrera IC; Courbebaisse M
    Clin Kidney J; 2024 Mar; 17(3):sfae040. PubMed ID: 38510798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystinuria: definition, epidemiology and clinical aspects.
    Trinchieri A; Dormia G; Montanari E; Zanetti G
    Arch Ital Urol Androl; 2004 Sep; 76(3):129-34. PubMed ID: 15568305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from Cystine to Noncystine Stones: Incidence and Associated Factors.
    Reinstatler L; Stern K; Batter H; Scotland KB; Ardekani GS; Rivera M; Chew BH; Eisner B; Krambeck AE; Monga M; Pais VM
    J Urol; 2018 Dec; 200(6):1285-1289. PubMed ID: 30059686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystinuria.
    Mattoo A; Goldfarb DS
    Semin Nephrol; 2008 Mar; 28(2):181-91. PubMed ID: 18359399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Urine Proteomic Profiling in Patients with Nephrolithiasis and Cystinuria.
    Assimos DG
    J Urol; 2019 Jul; 202(1):25. PubMed ID: 30932761
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria.
    Oliver KV; Vilasi A; Maréchal A; Moochhala SH; Unwin RJ; Rich PR
    Sci Rep; 2016 Oct; 6():34737. PubMed ID: 27721432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.